NCT01614210View on ClinicalTrials.gov

Preoperative Window of Endocrine Therapy Provides Information to Increase Compliance

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer
Interventions
DRUG

Tamoxifen

All patients will take tamoxifen 20 mg po daily for 7 days prior to surgery and for 14 days after surgery.

PROCEDURE

Breast cancer surgery

Breast cancer surgery

Trial Locations (1)

84112

Huntsman Cancer Institute, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT01614210 - Preoperative Window of Endocrine Therapy Provides Information to Increase Compliance | Biotech Hunter | Biotech Hunter